Hermann Russ

1.8k total citations
46 papers, 1.5k citations indexed

About

Hermann Russ is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Hermann Russ has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 15 papers in Neurology and 14 papers in Molecular Biology. Recurrent topics in Hermann Russ's work include Neuroscience and Neuropharmacology Research (16 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Neurological disorders and treatments (11 papers). Hermann Russ is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Neurological disorders and treatments (11 papers). Hermann Russ collaborates with scholars based in Germany, United States and France. Hermann Russ's co-authors include Thomas Müller, E. Sch�mig, Olivier Rascol, Christopher G. Goetz, Philippe Damier, C. Warren Olanow, Eugene Laska, Christine Hicking, Fátima Martel and H. Przuntek and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Hermann Russ

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hermann Russ Germany 23 807 699 360 182 166 46 1.5k
Felix Cruz-Sánchez Spain 18 520 0.6× 310 0.4× 384 1.1× 42 0.2× 247 1.5× 38 1.6k
B. B. Mršulja Romania 16 546 0.7× 287 0.4× 460 1.3× 51 0.3× 81 0.5× 57 1.3k
Erik Pileblad Sweden 22 598 0.7× 355 0.5× 329 0.9× 53 0.3× 65 0.4× 31 1.2k
Joakim Tedroff Sweden 28 1.5k 1.8× 948 1.4× 615 1.7× 34 0.2× 381 2.3× 86 2.5k
Molina Mhatre United States 22 836 1.0× 308 0.4× 580 1.6× 39 0.2× 179 1.1× 35 1.8k
Mitsutoshi Yamamoto Japan 28 705 0.9× 1.4k 2.0× 445 1.2× 28 0.2× 174 1.0× 69 2.1k
Jean‐Marie Maloteaux Belgium 26 1.1k 1.3× 330 0.5× 845 2.3× 51 0.3× 139 0.8× 70 1.9k
D. Duverger France 17 695 0.9× 250 0.4× 486 1.4× 59 0.3× 102 0.6× 24 1.6k
Ernest Dorflinger United States 14 395 0.5× 882 1.3× 225 0.6× 44 0.2× 198 1.2× 18 1.7k
David Virley United Kingdom 25 689 0.9× 339 0.5× 755 2.1× 49 0.3× 211 1.3× 51 2.1k

Countries citing papers authored by Hermann Russ

Since Specialization
Citations

This map shows the geographic impact of Hermann Russ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hermann Russ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hermann Russ more than expected).

Fields of papers citing papers by Hermann Russ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hermann Russ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hermann Russ. The network helps show where Hermann Russ may publish in the future.

Co-authorship network of co-authors of Hermann Russ

This figure shows the co-authorship network connecting the top 25 collaborators of Hermann Russ. A scholar is included among the top collaborators of Hermann Russ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hermann Russ. Hermann Russ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barkana, Yaniv, et al.. (2021). Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration. Scientific Reports. 11(1). 4764–4764. 2 indexed citations
2.
3.
Sommer, Susanne, Wojciech Danysz, Hermann Russ, et al.. (2014). The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. The International Journal of Neuropsychopharmacology. 17(12). 2045–2056. 63 indexed citations
4.
Suckfüll, M., Michael Althaus, Barbara Ellers‐Lenz, et al.. (2011). A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. PubMed. 11(1). 1–1. 39 indexed citations
5.
Woitalla, Dirk, et al.. (2007). The Management Approaches to Dyskinesia Vary from Country to Country. Neuroepidemiology. 29(3-4). 163–169. 6 indexed citations
6.
Ellrichmann, Gisa, Hermann Russ, & Tobias Müller. (2007). Dyskinesien bei Morbus Parkinson - Klinik, Ätiologie, Therapie. Fortschritte der Neurologie · Psychiatrie. 75(7). 387–396. 1 indexed citations
7.
Müller, Thomas, et al.. (2007). Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease. Journal of Neural Transmission. 114(8). 1023–1026. 12 indexed citations
8.
Olanow, C. Warren, Philippe Damier, Christopher G. Goetz, et al.. (2004). Multicenter, Open-Label, Trial of Sarizotan in Parkinson Disease Patients With Levodopa-Induced Dyskinesias (the SPLENDID Study). Clinical Neuropharmacology. 27(2). 58–62. 148 indexed citations
9.
Schömig, Edgar, et al.. (1997). The Extraneuronal Monoamine Transporter Exists in Human Central Nervous System Glia. Advances in pharmacology. 42. 356–359. 22 indexed citations
10.
Mühlbauer, Bernd, Gerd Luippold, Volker Vallon, et al.. (1997). Disprocynium24 induces a dopamine-independent, eukaliuric diuresis and natriuresis in the anaesthetized rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 356(6). 846–849. 2 indexed citations
11.
Russ, Hermann, et al.. (1996). The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(3). 275–86. 23 indexed citations
12.
Russ, Hermann, et al.. (1996). Pharmacokinetic and ?1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(3). 268–74. 14 indexed citations
13.
Eisenhofer, Graeme, Richard McCarty, Karel Pacák, et al.. (1996). Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 354(3). 287–94. 32 indexed citations
14.
Russ, Hermann, et al.. (1996). The Extraneuronal Transporter for Monoamine Transmitters Exists in Cells Derived from Human Central Nervous System Glia. European Journal of Neuroscience. 8(6). 1256–1264. 89 indexed citations
15.
Babin–Ebell, Jörg, et al.. (1994). The neuronal transport mechanism for noradrenaline is not influenced by the ATP analogue ATPγS. Life Sciences. 55(15). PL267–PL270. 1 indexed citations
16.
Russ, Hermann, et al.. (1993). Isocyanines and pseudoisocyanines as a novel class of potent noradrenaline-transport inhibitors: synthesis, detection, and biological activity. Journal of Medicinal Chemistry. 36(26). 4208–4213. 28 indexed citations
17.
Russ, Hermann, et al.. (1993). Cyanine-related compounds: a novel class of potent inhibitors of extraneuronal noradrenaline transport. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(5). 458–65. 44 indexed citations
18.
Russ, Hermann, Walter Mihatsch, Manfred Gerlach, Peter Riederer, & H. Przuntek. (1991). Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?. Neuroscience Letters. 123(1). 115–118. 54 indexed citations
19.
Schömig, Edgar, et al.. (1991). Extraneuronal inactivation of noradrenaline in tissue culture. PubMed. 34. 43–49. 2 indexed citations
20.
Mihatsch, Walter, Hermann Russ, & H. Przuntek. (1988). Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: Effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine. Journal of Neural Transmission. 71(3). 177–188. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felix Cruz-Sánchez Breakdown of academic impact, for papers by B. B. Mršulja Breakdown of academic impact, for papers by Erik Pileblad Breakdown of academic impact, for papers by Joakim Tedroff Breakdown of academic impact, for papers by Molina Mhatre Breakdown of academic impact, for papers by Mitsutoshi Yamamoto Breakdown of academic impact, for papers by Jean‐Marie Maloteaux Breakdown of academic impact, for papers by D. Duverger Breakdown of academic impact, for papers by Ernest Dorflinger Breakdown of academic impact, for papers by David Virley
Rankless by CCL
2026